Practice-Based Insights to Help Optimize Endocrine Therapy Duration in Early-Stage HR+ Breast Cancer

An expert exchange with Dr. Rena Callahan* (UCLA) and Dr. Vijay Paryani* (Duke Health) focused on:

• Navigating evolving genomic testing options to help inform treatment recommendations
• Integrating recent-meta-analysis results into individualized patient care
• Translating data into personalized clinical decisions through patient case reviews

*Speakers listed are consultants of Biotheranostics, Inc. Statements reflect the speakers’ own personal views and interpretations.